Has Wallace Chun, MD received payments from drug or device companies?

Yes. Drug and device makers reported $435 in general payments to Wallace Chun, MD across 24 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Wallace Chun, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Wallace Chun, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Wallace Chun, MD

Emergency Medicine · Post Falls, IDNPI 1427041730

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 24 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by AbbVie at 32.3% of the total. Among emergency medicine clinicians in ID with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$435in general payments, 2019–2025

Across 24 payments — averaging $18.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$140
Lilly USA, LLC$82
Merck$46
Novo Nordisk$30
Johnson & Johnson$21
E.r. Squibb & Sons, L.L.C.$21
plus $94 from 6 others

What the payments were for

Food & beverage$435100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	7	$140
Lilly USA, LLC	5	$82
Merck	2	$46
Novo Nordisk	2	$30
Johnson & Johnson	1	$21
E.r. Squibb & Sons, L.L.C.	1	$21
Pfizer	1	$18
Amgen	1	$17
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	1	$16
AstraZeneca	1	$15
Bayer	1	$14
Otsuka America Pharmaceutical, Inc.	1	$13

How this compares

$435 in reported general payments places this provider in the 90th percentile of 222 emergency medicine providers in Idaho.

See all emergency medicine providers in Idaho →

Medicare billing

Part B allowed, 2024

$43,750

Medicare patients

408

Services billed

477

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Cephalexin	72	$418
CefuroximeCefuroxime Axetil	17	$396
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	49	$336
Albuterol Sulfate HfaAlbuterol Sulfate	12	$251
Doxycycline Hyclate	23	$226
Azithromycin	30	$152
Prednisone	71	$146
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst	11	$138
ErythromycinErythromycin Base	13	$117
Ondansetron OdtOndansetron	12	$78
Amoxicillin	15	$35

Paid to pharmacies, not to this prescriber.